Enveric Biosciences, Inc. SEC filings ENVB

Enveric Biosciences, Inc. has 1,000 filings in SEC EDGAR's recent list, going back to Jul 30, 2001. Its latest annual report, Form ARS, was filed on Apr 14, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 14, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Aug 14, 2026 (results of operations). The company's fiscal year ends on December 31.

Enveric Biosciences, Inc. SEC filings
Form Description Filed Period
SCHEDULE 13G Ownership over 5% (passive) Nov 3, 2026 —
10-Q Quarterly report Aug 14, 2026 Jun 30, 2026
8-K Current report
Results of operations
Aug 14, 2026 Aug 14, 2026
SCHEDULE 13G/A Amended ownership over 5% (passive) Aug 14, 2026 —
SCHEDULE 13G Ownership over 5% (passive) Aug 14, 2026 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Aug 13, 2026 —
8-K Current report
Other events
Jun 9, 2026 Jun 9, 2026
424B5 Prospectus supplement Jun 9, 2026 —
8-K Current report
Regulation FD disclosure
Jun 9, 2026 Jun 8, 2026
4 Insider transaction Jun 3, 2026 Jun 1, 2026
4 Insider transaction Jun 3, 2026 Jun 1, 2026
4 Insider transaction Jun 3, 2026 Jun 1, 2026
4 Insider transaction Jun 3, 2026 Jun 1, 2026
4 Insider transaction Jun 3, 2026 Jun 1, 2026
4 Insider transaction Jun 3, 2026 Jun 1, 2026
4 Insider transaction Jun 3, 2026 Jun 1, 2026
4 Insider transaction Jun 3, 2026 Jun 1, 2026
S-8 Employee stock plan registration Jun 1, 2026 —
8-K Current report
Officer or director change, Shareholder vote results
May 29, 2026 May 22, 2026
SCHEDULE 13G/A Amended ownership over 5% (passive) May 15, 2026 —
10-Q Quarterly report May 15, 2026 Mar 31, 2026
8-K Current report
Results of operations
May 15, 2026 May 15, 2026
D Filing May 4, 2026 —
8-K Current report
Other events
Apr 30, 2026 Apr 30, 2026
DEFA14A Additional proxy material Apr 30, 2026 —
EFFECT Filing Apr 29, 2026 —
424B3 Prospectus Apr 29, 2026 —
CORRESP Letter to the SEC Apr 28, 2026 —
UPLOAD Letter from the SEC Apr 27, 2026 —
S-3 Shelf registration Apr 23, 2026 —
8-K Current report
Material agreement, Unregistered share sale, Other events
Apr 20, 2026 Apr 16, 2026
ARS Annual report to shareholders Apr 14, 2026 Dec 31, 2025
DEFA14A Additional proxy material Apr 14, 2026 —
DEF 14A Proxy statement Apr 14, 2026 Apr 14, 2026
PRE 14A Preliminary proxy statement Apr 3, 2026 Apr 3, 2026
10-K Annual report Mar 27, 2026 Dec 31, 2025
8-K Current report
Results of operations
Mar 27, 2026 Mar 27, 2026
424B3 Prospectus Feb 18, 2026 —
EFFECT Filing Feb 17, 2026 —
CORRESP Letter to the SEC Feb 17, 2026 —
UPLOAD Letter from the SEC Feb 17, 2026 —
D Filing Feb 11, 2026 —
S-1 Registration statement Feb 10, 2026 —
8-K Current report
Other events
Feb 6, 2026 Feb 6, 2026
424B5 Prospectus supplement Feb 6, 2026 —
SCHEDULE 13G Ownership over 5% (passive) Feb 4, 2026 —
SCHEDULE 13G Ownership over 5% (passive) Feb 2, 2026 —
8-K Current report
Material agreement, Unregistered share sale
Jan 28, 2026 Jan 27, 2026
424B5 Prospectus supplement Jan 28, 2026 —
8-K Current report
Regulation FD disclosure
Jan 9, 2026 Jan 9, 2026
SCHEDULE 13G/A Amended ownership over 5% (passive) Jan 5, 2026 —
424B3 Prospectus Dec 31, 2025 —
EFFECT Filing Dec 30, 2025 —
4 Insider transaction Dec 30, 2025 Dec 23, 2025
4 Insider transaction Dec 30, 2025 Dec 23, 2025
4 Insider transaction Dec 30, 2025 Dec 23, 2025
4 Insider transaction Dec 30, 2025 Dec 23, 2025
4 Insider transaction Dec 30, 2025 Dec 23, 2025
4 Insider transaction Dec 30, 2025 Dec 23, 2025
4 Insider transaction Dec 30, 2025 Dec 23, 2025
CORRESP Letter to the SEC Dec 29, 2025 —
D Filing Dec 23, 2025 —
UPLOAD Letter from the SEC Dec 23, 2025 —
S-3 Shelf registration Dec 22, 2025 —
S-8 Employee stock plan registration Dec 22, 2025 —
SCHEDULE 13G Ownership over 5% (passive) Dec 17, 2025 —
8-K Current report
Material agreement, Unregistered share sale
Dec 12, 2025 Dec 11, 2025
8-K Current report
Shareholder vote results
Dec 11, 2025 Dec 11, 2025
SCHEDULE 13G/A Amended ownership over 5% (passive) Dec 10, 2025 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Dec 10, 2025 —
424B3 Prospectus Dec 10, 2025 —
EFFECT Filing Dec 8, 2025 —
CORRESP Letter to the SEC Dec 8, 2025 —
SCHEDULE 13G Ownership over 5% (passive) Dec 5, 2025 —
SCHEDULE 13G Ownership over 5% (passive) Dec 5, 2025 —
S-3/A Filing Dec 5, 2025 —
10-Q Quarterly report Nov 14, 2025 Sep 30, 2025
8-K Current report
Other events
Nov 14, 2025 Nov 12, 2025
8-K Current report
Results of operations
Nov 14, 2025 Nov 14, 2025
SCHEDULE 13G Ownership over 5% (passive) Nov 13, 2025 —
DEF 14A Proxy statement Oct 27, 2025 Oct 27, 2025
8-K Current report
Listing notice, Change to shareholder rights, Bylaw or fiscal year change, Other events
Oct 23, 2025 Oct 22, 2025
PRE 14A Preliminary proxy statement Oct 10, 2025 Oct 10, 2025
SCHEDULE 13G Ownership over 5% (passive) Oct 3, 2025 —
D Filing Oct 3, 2025 —
UPLOAD Letter from the SEC Sep 30, 2025 —
S-3 Shelf registration Sep 29, 2025 —
SCHEDULE 13G Ownership over 5% (passive) Sep 24, 2025 —
8-K Current report
Material agreement, Unregistered share sale
Sep 18, 2025 Sep 17, 2025
8-K Current report
Regulation FD disclosure, Other events
Sep 2, 2025 Sep 2, 2025
8-K Current report
Regulation FD disclosure
Aug 29, 2025 Aug 29, 2025
8-K Current report
Listing notice
Aug 29, 2025 Aug 26, 2025
10-Q Quarterly report Aug 14, 2025 Jun 30, 2025
8-K Current report
Results of operations
Aug 14, 2025 Aug 14, 2025
8-K Current report
Shareholder vote results
Jun 3, 2025 May 29, 2025
10-Q Quarterly report May 14, 2025 Mar 31, 2025
8-K Current report
Results of operations
May 14, 2025 May 14, 2025
4 Insider transaction May 12, 2025 May 8, 2025
4 Insider transaction May 12, 2025 May 8, 2025
4 Insider transaction May 12, 2025 May 8, 2025
EFFECT Filing Apr 17, 2025 —
CORRESP Letter to the SEC Apr 16, 2025 —
ARS Annual report to shareholders Apr 16, 2025 Dec 31, 2024
DEFA14A Additional proxy material Apr 15, 2025 —
DEF 14A Proxy statement Apr 15, 2025 Apr 15, 2025
8-K Current report
Auditor change
Apr 14, 2025 Apr 14, 2025
S-3/A Filing Apr 10, 2025 —
PRE 14A Preliminary proxy statement Apr 4, 2025 Dec 31, 2024
SCHEDULE 13G/A Amended ownership over 5% (passive) Apr 2, 2025 —
8-K Current report
Results of operations
Mar 31, 2025 Mar 31, 2025
10-K Annual report Mar 28, 2025 Dec 31, 2024
S-8 Employee stock plan registration Mar 24, 2025 —
8-K Current report
Other events
Mar 6, 2025 Mar 4, 2025
8-K Current report
Regulation FD disclosure
Feb 26, 2025 Feb 26, 2025
SCHEDULE 13G Ownership over 5% (passive) Feb 5, 2025 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Feb 4, 2025 —
SCHEDULE 13G Ownership over 5% (passive) Feb 4, 2025 —
8-K Current report
Material agreement, Other events
Feb 3, 2025 Jan 30, 2025
424B4 Prospectus Feb 3, 2025 —
EFFECT Filing Jan 30, 2025 —
S-1/A Amended registration statement Jan 30, 2025 —
CORRESP Letter to the SEC Jan 30, 2025 —
S-1/A Amended registration statement Jan 30, 2025 —
8-K/A Amended current report
Bylaw or fiscal year change
Jan 27, 2025 Jan 24, 2025
8-K Current report
Change to shareholder rights, Bylaw or fiscal year change, Shareholder vote results
Jan 21, 2025 Jan 17, 2025
UPLOAD Letter from the SEC Jan 21, 2025 —
S-1 Registration statement Jan 14, 2025 —
SCHEDULE 13G Ownership over 5% (passive) Jan 6, 2025 —
8-K Current report
Regulation FD disclosure
Jan 3, 2025 Jan 3, 2025
UPLOAD Letter from the SEC Dec 19, 2024 —
DEF 14A Proxy statement Dec 18, 2024 Dec 18, 2024
PRER14A Filing Dec 12, 2024 —
PRE 14A Preliminary proxy statement Nov 27, 2024 Nov 27, 2024
8-K Current report
Listing notice
Nov 22, 2024 Nov 20, 2024
10-Q Quarterly report Nov 14, 2024 Sep 30, 2024
8-K Current report
Results of operations
Nov 14, 2024 Nov 14, 2024
SC 13G/A Amended ownership over 5% (passive) Nov 14, 2024 —
SC 13G/A Amended ownership over 5% (passive) Nov 13, 2024 —
SC 13G/A Amended ownership over 5% (passive) Nov 12, 2024 —
8-K Current report
Material agreement, Other events
Nov 12, 2024 Nov 7, 2024
4 Insider transaction Oct 11, 2024 Oct 9, 2024
4 Insider transaction Oct 11, 2024 Oct 9, 2024
4 Insider transaction Oct 11, 2024 Oct 9, 2024
4 Insider transaction Oct 11, 2024 Oct 9, 2024
4 Insider transaction Oct 11, 2024 Oct 9, 2024
4 Insider transaction Oct 11, 2024 Oct 9, 2024
4 Insider transaction Oct 11, 2024 Oct 9, 2024
4 Insider transaction Oct 11, 2024 Oct 9, 2024
424B4 Prospectus Sep 12, 2024 —
EFFECT Filing Sep 11, 2024 —
CORRESP Letter to the SEC Sep 10, 2024 —
UPLOAD Letter from the SEC Sep 9, 2024 —
S-1 Registration statement Sep 4, 2024 —
8-K Current report
Regulation FD disclosure
Aug 22, 2024 Aug 22, 2024
10-Q Quarterly report Aug 12, 2024 Jun 30, 2024
8-K Current report
Results of operations
Aug 12, 2024 Aug 12, 2024
8-K Current report
Material agreement, Other events
Jul 15, 2024 Jul 10, 2024
UPLOAD Letter from the SEC Jul 12, 2024 —
S-3 Shelf registration Jul 8, 2024 —
3 Initial insider ownership Jun 3, 2024 May 28, 2024
8-K Current report
Shareholder vote results
May 29, 2024 May 28, 2024
8-K Current report
Listing notice
May 23, 2024 May 21, 2024
8-K Current report
Listing notice
May 17, 2024 May 16, 2024
10-Q Quarterly report May 15, 2024 Mar 31, 2024
8-K Current report
Results of operations
May 15, 2024 May 15, 2024
424B5 Prospectus supplement May 3, 2024 —
8-K Current report
Material agreement
May 3, 2024 May 3, 2024
ARS Annual report to shareholders Apr 16, 2024 Dec 31, 2023
DEF 14A Proxy statement Apr 16, 2024 Apr 16, 2024
8-K Current report Mar 28, 2024 Mar 27, 2024
8-K Current report
Results of operations
Mar 26, 2024 Mar 26, 2024
10-K Annual report Mar 26, 2024 Dec 31, 2023
8-K Current report
Regulation FD disclosure
Mar 19, 2024 Mar 19, 2024
424B5 Prospectus supplement Mar 11, 2024 —
8-K Current report
Material agreement
Mar 11, 2024 Mar 8, 2024
8-K Current report
Regulation FD disclosure
Feb 29, 2024 Feb 29, 2024
4 Insider transaction Feb 26, 2024 Feb 22, 2024
4 Insider transaction Feb 26, 2024 Feb 22, 2024
4 Insider transaction Feb 26, 2024 Feb 22, 2024
8-K Current report
Regulation FD disclosure
Feb 21, 2024 Feb 21, 2024
SC 13G Ownership over 5% (passive) Feb 14, 2024 —
8-K Current report
Listing notice
Feb 9, 2024 Feb 6, 2024
SC 13G/A Amended ownership over 5% (passive) Feb 6, 2024 —
SC 13G/A Amended ownership over 5% (passive) Feb 5, 2024 —
424B3 Prospectus Jan 24, 2024 —
EFFECT Filing Jan 22, 2024 —
CORRESP Letter to the SEC Jan 19, 2024 —
UPLOAD Letter from the SEC Jan 16, 2024 —
S-3 Shelf registration Jan 11, 2024 —
8-K Current report
Exit or restructuring costs
Jan 8, 2024 Jan 8, 2024
8-K Current report
Regulation FD disclosure
Jan 3, 2024 Jan 3, 2024
8-K Current report
Material agreement, Unregistered share sale, Change to shareholder rights
Dec 29, 2023 Dec 28, 2023
8-K Current report
Regulation FD disclosure
Dec 28, 2023 Dec 28, 2023
8-K Current report
Regulation FD disclosure
Dec 27, 2023 Dec 27, 2023
424B4 Prospectus Dec 6, 2023 —
EFFECT Filing Dec 5, 2023 —
8-K Current report
Regulation FD disclosure
Dec 5, 2023 Dec 5, 2023
CORRESP Letter to the SEC Dec 4, 2023 —
S-1/A Amended registration statement Dec 1, 2023 —
8-K Current report
Regulation FD disclosure
Nov 29, 2023 Nov 29, 2023

Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Pharmaceutical Preparations (SIC 2834)
Listed as
ENVB (Nasdaq)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
Cambridge, MA
SEC filer status
Non-accelerated filer, Smaller reporting company
SEC CIK
890821
Former names
AMERI Holdings, Inc. (until Dec 30, 2020); SPATIALIZER AUDIO LABORATORIES INC (until May 27, 2015)

Other Pharmaceutical Preparations companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.